Ambisome and Management of Culture-negative Neutropenic Fever Unresponsive to Antibiotics
Is a
Allocation Type
Randomized
0
Participating Facility
Health Conditions in Trial
Intervention Model
Parallel Assignment
0
Interventional Trial Phase
Phase 4
0
Interventional Trial Purpose
Treatment
0
Intervention Treatment
Liposomal amphotericin B (AmBisome®)
0
Intervention Type
Drug
0
Last Updated
March 11, 2011
0
Masking Type
None (Open Label)
0
Primary Completion Date
2008
0
Trial Recruitment Size
20
0
Trial Sponsor
Clinical Trial Start Date
2007
0
Study Completion Date
2008
0
Clinical Trial Study Type
Interventional
0
NCT Number
Official Name
Phase III Study of 3 Sequential Doses (10 mg/kg, 5 mg/kg, and 5 mg/kg) vs 3 mg/kg/Day of AmBisome® in the Management of Culture-negative Neutropenic Fever Unresponsive to Antibiotics
0
Official Website
Find more entities like Ambisome and Management of Culture-negative Neutropenic Fever Unresponsive to Antibiotics
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.